Encouraging investigator-initiated research grant applications of therapeutic and pathogenic approaches for the muscular dystrophies. Responses to this program announcement may include studies in appropriate animal models or preclinical or clinical studies in patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), limb-girdle muscular dystrophy (LGMD), myotonic dystrophy (DM), congenital muscular dystrophy (CMD), Emery-Dreifuss muscular dystrophy (EMD), or other forms of muscular dystrophy.